Nanoparticle-Based Drug Delivery Systems for Tumor Treatment: Advancing Solutions to Overcome Drug Resistance

• Chiranjeev Singh

  Department of Pharmacy, Kalinga University, Raipur, India

• Prachi Gurudiwan

  Department of Pharmacy, Kalinga University, Raipur, India

The potential of nanoparticles (NPs) as a drug delivery mechanism (DDM) has prompted extensive study and use of nanotechnology in tumor cell (TC) treatment. Compared to conventional medications, NP-based DDM offers greater stability and biocompatibility, enhanced absorption and preservation, and focused accuracy, which are some of its unique advantages. This drug-carrying technology has reached a new level with the use and improvement of composite nanoparticles (NPs), which combine the unique characteristics of multiple NPs. Additionally, NP-based DDMs have demonstrated effectiveness in overcoming cancer-related drug resistance (DR). Improving medical translation must address limited dose capacity, stability limitations, and potential harmful effects. Researchers are exploring ways to enhance DDM, including the development of novel drug-encapsulating techniques and modifications to NP surfaces. Potentially huge gains in treatment efficacy may result from optimizing medication integration in such systems. One obstacle to medical translation is stability issues. Applying protective covers and improving formulations are two methods that researchers are exploring to extend the lifespan of NPs.

Additionally, before progressing with clinical trials, efforts are being made to minimize the likelihood of negative side effects by carefully selecting compounds that are biologically compatible for NP synthesis and conducting comprehensive toxicity evaluations. Following that, we continue with the innovation of nanoparticle design and functionalization; these types of delivery systems are poised to play a key role in various areas of next-generation tumour therapies. Which provides various offers through robust pathways to overcoming drug resistance, accelerating clinical translation.

Verma S, Malviya R, Srivastava S, Ahmad I, Singh B, Almontasheri R, Uniyal P. Shape Dependent Therapeutic Potential of Nanoparticulate System: Advance Approach for Drug Delivery. Current Pharmaceutical Design 2024; 30(33): 2606-2618.

Kaplan A, Khan MN, Iqbal M, Wahab S, Wahid N, Ghazal M, Hayat K. NANO-drug delivery systems based on natural products and their bioavailability in biological systems. The Broad Spectrum of Biological Sciences 2024; 255.

Parvathi MA, Kumari M, Raj M, Singh M. Mechanism of anticancer therapy: from conventional to targeted drug delivery. Anticancer Therapeutics: Bionanotechnology, Nanomedicine and Phytochemicals 2024; 97.

https://app.biorender.com/

Sharma S, Sudhakara P, Singh J, Ilyas RA, Asyraf MRM, Razman MR. Critical review of biodegradable and bioactive polymer composites for bone tissue engineering and drug delivery applications. Polymers 2021; 13(16): 2623.

Rommasi F, Esfandiari N. Liposomal nanomedicine: applications for drug delivery in cancer therapy. Nanoscale Research Letters 2021; 16(1): 95.

Abdolmaleki A, Asadi A, Gurushankar K, Shayan TK, Sarvestani FA. Importance of nano medicine and new drug therapies for cancer. Advanced Pharmaceutical Bulletin 2021; 11(3): 450.

Sim S, Wong NK. Nanotechnology and its use in imaging and drug delivery. Biomedical Reports 2021; 14(5): 42.

Rasool M, Malik A, Waquar S, Arooj M, Zahid S, Asif M, Gan SH. New challenges in the use of nanomedicine in cancer therapy. Bioengineered 2022; 13(1): 759-773.

Nikzamir M, Hanifehpour Y, Akbarzadeh A, Panahi Y. Applications of dendrimers in nanomedicine and drug delivery: A review. Journal of Inorganic and Organometallic Polymers and Materials 2021; 31(6): 2246-2261.

Afshari AR, Sanati M, Mollazadeh H, Kesharwani P, Johnston TP, Sahebkar A. Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways. In Seminars in cancer biology. Academic Press 2022; Vol. 86: pp. 860-872.

Li S, Li L, Lin X, Chen C, Luo C, Huang Y. Targeted inhibition of tumor inflammation and tumor-platelet crosstalk by nanoparticle-mediated drug delivery mitigates cancer metastasis. ACS Nano 2021; 16(1): 50-67.

Tang L, Mei Y, Shen Y, He S, Xiao Q, Yin Y, Cai Z. Nanoparticle-mediated targeted drug delivery to remodel tumor microenvironment for cancer therapy. International Journal of Nanomedicine 2021; 5811-5829.

Hare JI, Lammers T, Ashford MB, Puri S, Storm G, Barry ST. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. Advanced Drug Delivery Reviews 2017; 108: 25-38.

• PDF

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.